lumasiran
Generic: LUMASIRAN SODIUM·Brand: OXLUMO, Oxlumo
lumasiran: 1 clinical trial tracked.
lumasiran evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about lumasiran, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence0 indications · 1 study sponsors
Related indications
No linked indication is available.
Study sponsors
Clinical Trial Registry Records (1)
ILLUMINATE-C: A Single Arm Study to Evaluate Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1 (PH1)
Primary endpoint: Cohort A: Percent Change in Plasma Oxalate From Baseline to Month 6
Interventionalopen21 enrolledStarted 2020-01Completion 2025-0614 sites · Australia, Belgium, France, Israel…Alnylam Pharmaceuticals